UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 175 filers reported holding UNIQURE NV in Q1 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,065,000 | +28.2% | 114,251 | +47.1% | 0.00% | 0.0% |
| Q4 2021 | $1,611,000 | -24.9% | 77,671 | +16.0% | 0.00% | 0.0% |
| Q3 2021 | $2,144,000 | +335.8% | 66,986 | +319.7% | 0.00% | – |
| Q2 2021 | $492,000 | -10.1% | 15,962 | -1.7% | 0.00% | – |
| Q1 2021 | $547,000 | +70.9% | 16,236 | +83.2% | 0.00% | – |
| Q4 2020 | $320,000 | +30.1% | 8,864 | +32.6% | 0.00% | – |
| Q3 2020 | $246,000 | -34.9% | 6,685 | +38.3% | 0.00% | – |
| Q2 2019 | $378,000 | +42.1% | 4,835 | +8.4% | 0.00% | – |
| Q1 2019 | $266,000 | – | 4,459 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |